心臓安全サービス市場の評価：タイプ・用途・エンドユーザー・地域別の機会および予測 (2017-2031年)

世界の心臓安全サービスの市場規模は、2023年の7億5,323万米ドルから、2024年から2031年の予測期間中は10.2%のCAGRで推移し、2031年には16億3,825万米ドルの規模に成長すると予測されています。

同市場は近年著しい成長を遂げており、今後も堅調な拡大ペースを維持すると予測されています。心臓安全サービスとは、医療専門家が心臓に関するあらゆる可能性のある機能不全リスクを検出し、重大な問題や致命的な状態を予防するために使用するデバイスを指します。これらのサービスには、心電図、血圧モニタリング、MUGAスキャン、長期ホルターモニタリングなどが含まれます。

心臓安全サービス市場は、今後数年間でさまざまな成長を示すと予測されています。老齢人口の増加、技術の進歩、定期的な健康診断を受けることに対する人々の意識、全体的な人口の増加が、この市場が成長する可能性を秘めているいくつかの理由です。ヘルスケアプロバイダーや業界大手は、患者のために最善の診断アプローチを提供するために協力しています。資金が調達され、政府機関だけでなく民間企業からも多額の投資が行われています。また、心血管疾患の罹患率の増加も、同市場の成長を促進すると予想されています。世界保健機関 (WHO) が2022年10月に更新した統計によると、脳卒中の生涯リスクは過去17年間で50％上昇しており、推定で4人に1人が生涯に脳卒中を経験すると予想されています。

心血管疾患の有病率の上昇：

心臓発作、不整脈、心不全は心血管疾患 (CVD) の一例であり、世界的に罹患率および死亡率の主要原因となっています。これらの疾患の発生率が上昇しているため、迅速な介入と治療計画は心電図 (ECG) のような精密な診断機器に依存しています。世界の高齢化により、心臓血管系の問題に対する脆弱性が高まっているため、心臓の健康を適切に監視・管理するための診断用ECG機器の必要性が強調されています。高齢になるにつれて心臓に関連する疾患にかかりやすくなるため、正確な測定値を示し、重大な問題を未然に防ぐことができる高度な診断機器が常に必要とされています。心電図機器の精度、使いやすさ、接続性は、継続的な技術改良の結果、すべて向上しています。ワイヤレスモニタリング、クラウドベースのデータストレージ、モバイルアプリケーションの導入により、在宅医療や臨床現場でのECG機器の使用が増加しています。これらの開発により、医療従事者による患者の心臓の状態の遠隔監視やタイムリーな介入が可能となり、全体として患者の転帰を改善させています。さらに、発展途上国では、診断センターの建設など、ヘルスケアのインフラ整備に多額の投資が行われています。ヘルスケアサービスへのアクセスが向上するだけでなく、このようなインフラ整備により、さまざまな機器を幅広く利用できる可能性が広がります。こうした発展は、医療格差の是正や、これまで医療技術へのアクセスが制限されていた地域の社会的弱者に対する医療水準の向上につながるため、特に重要です。WHOの報告によると、世界全体で、心血管疾患 (CVD) は年間1,790万人の死因を占め、死因の第1位となっています。心臓や血管の病気はCVDと呼ばれ、リウマチ性心疾患、冠状動脈性心疾患、脳血管疾患などが含まれます。心臓発作と脳卒中はCVDによる死因の5人に4人以上を占め、これらの死因の3分の1は70歳未満で早期に起こっています。

心臓安全サービスの技術的進歩：

診断機器の売上は、技術の進歩により大幅に拡大し、病気の発見と治療が向上しました。最新技術がこれらの機器に搭載され、可搬性、柔軟性、ワークフローが改善され、医師は検査中にワークステーションを容易に調整できるようになっています。さまざまな管理ソリューションのベンダーは、データ通信を改善し、クラウドやスマートフォンシステムなど、他のソフトウェアシステムへの幅広いアクセスや相互運用性を可能にするデジタル化の進行に意欲を燃やしています。心臓安全サービス市場は、新たな治療アプローチと技術改善によって牽引されると考えられています。

当レポートでは、世界の心臓安全サービスの市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の心臓安全サービス市場の展望

• 市場規模・予測
• タイプ別
  • 統合型サービス
  • スタンドアロン型サービス
• 用途別
  • ECG/ホルター測定サービス
  • 血圧測定サービス
  • 心臓血管画像診断サービス
  • Thorough QTサービス
  • その他
• エンドユーザー別
  • 製薬・バイオ医薬品企業
  • CRO
  • 学術・研究機関
• 地域別
  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ
• 企業別市場シェア

第6章 世界の心臓安全サービス市場の展望：地域別

• 北米
• 欧州
• 南米
• アジア太平洋
• 中東・アフリカ

第6章 市場マッピング

• タイプ別
• 用途別
• エンドユーザー別
• 地域別

第7章 マクロ環境・産業構造

• 需給分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

• 成長促進因子
• 成長阻害因子 (課題・制約)

第9章 イノベーション/新興技術

第10章 主要企業の情勢

• 市場リーダー上位5社の競合マトリックス
• 市場リーダー上位5社の市場収益分析
• M&A・ジョイントベンチャー (該当する場合)
• SWOT分析 (参入5社)
• 特許分析 (該当する場合)

第11章 ケーススタディ

第12章 主要企業の展望

• Laboratory Corporation of America Holdings
• Medpace Holdings, Inc.
• Koninklijke Philips N.V.
• Clario
• Ncardia Services B.V.
• IQVIA Holdings, Inc.
• Certara, Inc.
• ICON PLC.
• WuXi Biologics Cayman Inc.
• Eurofins Biopharma Product Testing India Pvt Ltd

第13章 戦略的提言

第14章 当社について・免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1.Global Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 2.Global Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 3.Global Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 4.Global Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 5.Global Cardiac Safety Services Market Share (%), By Region, 2017-2031F
• Figure 6.North America Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 7.North America Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 8.North America Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 9.North America Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 10.North America Cardiac Safety Services Market Share (%), By Country, 2017-2031F
• Figure 11.United States Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 12.United States Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 13.United States Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 14.United States Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 15.Canada Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 16.Canada Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 17.Canada Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 18.Canada Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 19.Mexico Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 20.Mexico Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 21.Mexico Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 22.Mexico Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 23.Europe Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 24.Europe Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 25.Europe Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 26.Europe Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 27.Europe Cardiac Safety Services Market Share (%), By Country, 2017-2031F
• Figure 28.Germany Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 29.Germany Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 30.Germany Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 31.Germany Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 32.France Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 33.France Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 34.France Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 35.France Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 36.Italy Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 37.Italy Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 38.Italy Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 39.Italy Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 40.United Kingdom Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 41.United Kingdom Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 42.United Kingdom Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 43.United Kingdom Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 44.Russia Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 45.Russia Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 46.Russia Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 47.Russia Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 48.Netherlands Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 49.Netherlands Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 50.Netherlands Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 51.Netherlands Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 52.Spain Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 53.Spain Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 54.Spain Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 55.Spain Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 56.Turkey Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 57.Turkey Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 58.Turkey Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 59.Turkey Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 60.Poland Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 61.Poland Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 62.Poland Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 63.Poland Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 64.South America Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 65.South America Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 66.South America Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 67.South America Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 68.South America Cardiac Safety Services Market Share (%), By Country, 2017-2031F
• Figure 69.Brazil Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 70.Brazil Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 71.Brazil Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 72.Brazil Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 73.Argentina Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 74.Argentina Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 75.Argentina Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 76.Argentina Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 77.Asia-Pacific Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 78.Asia-Pacific Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 79.Asia-Pacific Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 80.Asia-Pacific Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 81.Asia-Pacific Cardiac Safety Services Market Share (%), By Country, 2017-2031F
• Figure 82.India Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 83.India Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 84.India Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 85.India Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 86.China Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 87.China Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 88.China Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 89.China Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 90.Japan Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 91.Japan Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 92.Japan Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 93.Japan Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 94.Australia Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 95.Australia Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 96.Australia Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 97.Australia Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 98.Vietnam Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 99.Vietnam Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 100.Vietnam Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 101.Vietnam Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 102.South Korea Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 103.South Korea Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 104.South Korea Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 105.South Korea Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 106.Indonesia Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 107.Indonesia Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 108.Indonesia Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 109.Indonesia Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 110.Philippines Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 111.Philippines Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 112.Philippines Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 113.Philippines Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 114.Middle East & Africa Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 115.Middle East & Africa Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 116.Middle East & Africa Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 117.Middle East & Africa Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 118.Middle East & Africa Cardiac Safety Services Market Share (%), By Country, 2017-2031F
• Figure 119.Saudi Arabia Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 120.Saudi Arabia Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 121.Saudi Arabia Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 122.Saudi Arabia Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 123.UAE Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 124.UAE Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 125.UAE Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 126.UAE Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 127.South Africa Cardiac Safety Services Market, By Value, In USD Million, 2017-2031F
• Figure 128.South Africa Cardiac Safety Services Market Share (%), By Type, 2017-2031F
• Figure 129.South Africa Cardiac Safety Services Market Share (%), By Application Type, 2017-2031F
• Figure 130.South Africa Cardiac Safety Services Market Share (%), By End-user, 2017-2031F
• Figure 131.By Type Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 132.By Application Type Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 133.By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 134.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023

Global cardiac safety services market is projected to witness a CAGR of 10.2% during the forecast period 2024-2031, growing from USD 753.23 million in 2023 to USD 1638.25 million by 2031. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years. Cardiac safety services are devices that are used by healthcare professionals to detect the risk of any possible heart-related malfunctions to prevent any major problems or conditions that may be fatal. These services include ECG, blood pressure monitoring, multi-gated acquisition scans, long-term Holter monitoring, and more tests.

Cardiac safety services market is expected to grow manifold in the coming years. A rising geriatric population, technological advancements, awareness among people about getting regular health check-ups, and an overall increasing population are a few reasons why this market has the potential to grow. Healthcare providers and industry giants are coming together to bring out their best diagnostic approaches for patients. Funds are being raised, and a hefty amount is being invested by both governmental bodies as well as private companies. Strategic movements like acquisitions and mergers, investments, and partnerships come into play when these huge companies are trying to launch or develop a new product. This market holds significant importance because of how important it is to diagnose the root causes of any heart-related condition beforehand to avoid serious outcomes. Additionally, it is anticipated that the growing incidence of cardiovascular illnesses will support the segment's expansion. Statistics updated by the World Health Organisation, in October 2022, show that the lifetime risk of stroke has risen by 50% in the past 17 years, with an estimated 1 in 4 people expected to experience a stroke in their lifetime.

Rising Prevalence of Cardiovascular Diseases

Heart attacks, arrhythmias, and heart failure are examples of cardiovascular diseases (CVDs), which are leading causes of morbidity and mortality globally. Owing to the rising incidence of these disorders, prompt intervention and treatment planning depend on precise diagnostic instruments like electrocardiograms (ECGs). The aging population of the world emphasizes the necessity of diagnostic ECG devices in order to properly monitor and manage heart health because of their increased vulnerability to cardiovascular issues. People are becoming more susceptible to heart-related conditions as they get older, which means there will always be a need for advanced diagnostic equipment that can give precise readings and prevent any major issues. The accuracy, usability, and connectivity aspects of ECG equipment have all improved as a result of ongoing technical improvements. The use of ECG devices in home care and clinical settings has increased with the incorporation of wireless monitoring, cloud-based data storage, and mobile applications. These developments improve patient outcomes overall by enabling medical practitioners to remotely monitor patients' cardiac conditions and enable timely intervention. Moreover, developing nations are investing heavily in the infrastructure of healthcare, including the construction of diagnostic centers. In addition to facilitating better access to healthcare services, this infrastructural development opens possibilities for the broad use of various equipment. These developments are especially important since they close the gap in healthcare disparities and raise the standard of care for marginalized communities in places where access to medical technologies was previously restricted. According to a report by the WHO, globally, cardiovascular diseases (CVDs) account for 17.9 million deaths annually, making them the leading cause of death. Heart and blood vessel illnesses, together referred to as CVDs, include rheumatic heart disease, coronary heart disease, and cerebrovascular disease. Heart attacks and strokes account for more than four out of every five deaths from CVD, and one-third of these deaths happen too soon among those under the age of 70.

Technological Advancements in Cardiac Safety Services

The sales of diagnostic equipment have expanded significantly as a result of advanced technology, improving disease detection and treatment. The latest technologies are now included with these devices to improve portability, flexibility, and workflow, allowing doctors to easily adjust workstations during exams. Vendors of various management solutions have been motivated by the ongoing digitalization to improve data communication, allowing for wider access and interoperability with other software systems, such as cloud and smartphone systems. Well-known manufacturers are committed to offering cutting-edge features and applications for their diagnostic machines, including GE Healthcare's CASE exercise testing system. The cardiac safety services market will be driven by new therapeutic approaches and technological improvements. With the use of the Exercise Testing System, ambulatory ECG, pacemaker, Holter monitor, and event monitor, it is now possible to effectively treat the increasing number of instances of arrhythmia, cardiomyopathy, and coronary artery disease. In the US, pacemakers are implanted in almost 2.6 out of every 1000 people to address a variety of heart diseases, according to an NCBI study. The elderly are more likely to use pacemakers than other age groups: 0.4 out of 1000 persons in the 18-64 age group and 26 out of 1000 people in the 65+ age group use pacemakers.

Increasing Demand for ECG/Holter Measurement Segment

A Holter monitor is a battery-operated portable ECG device that can be worn by a patient for 24 to 48 hours, records heart activity (electrocardiogram) continuously, and monitors the heart rhythm. Patients and doctors are using this portable ECG equipment more frequently because it has various benefits over standard ECG devices, including fewer leads and the ability to allow the patient to move around and go about their regular daily activities. Segment growth is anticipated to be aided by the growing geriatric population and the rising incidence of cardiovascular diseases.

The American Heart Association published its data in December 2022, which showed older patients had more pronounced anatomical changes and more severe functional impairment during heart diseases. Aging-related cardiovascular changes also increase the risk of acute coronary syndrome (ACS) and may complicate its diagnosis and treatment. It occurs because big arteries experience blockage with age. The heart muscle pumps less effectively, even if it works harder, due to blockage. Therefore, it is anticipated that the use of ECG/Holter measurement services will increase due to the growing problems of cardiovascular diseases with aging. A groundbreaking 12-lead ECG-integrated solution for at-home use in decentralized clinical trials was revealed by Koninklijke Philips in January 2022. This innovation aims to reduce the need for, and burden associated with traditional clinical trials, thereby improving patient retention, compliance, and trial outcomes.

North America to Dominate the Cardiac Safety Services Market

Due to the rising number of elderly patients and the high incidence of cardiovascular illnesses, North America is anticipated to account for a sizable portion of the global market for cardiac safety services throughout the projection period.

For example, the Center for Disease Control and Prevention (CDC) updated its data in October 2022 and estimated that approximately 805,000 Americans experience a heart attack annually, of which 605,000 are estimated to be first-time heart attack victims and 200,000 are heart attack survivors. Additionally, it is anticipated that the region's aging population will raise the prevalence of cardiovascular illnesses, which will increase the use of cardiac safety services. In July 2022, Statistics Canada released data projecting that 7,330,605 Canadians, 65 years of age or older, comprise 18.8%

of the country's overall population. AliveCor unveiled the KardiaMobileCard in February 2022, which is the most practical and svelte personal electrocardiogram (PECG) device in the US market. It is the only portable ECG device that is small enough to put in a wallet and offers real-time, anytime, anywhere heart health information.

Future Market Scenario (2024-2031F)

The rising prevalence of cardiovascular diseases in the population is one of the biggest reasons why the cardiac safety services market is expected to grow in the forecast period. Heart attacks are shown to be the most widespread among all and are very common, which raises concern and hence requires a quick diagnosis. Technology and diagnostic approaches that are effective and cost-efficient are being introduced by players in this industry who are growing at an unmatched pace. The government is taking initiatives, bringing in new policies, and raising funds to improve the shape of healthcare around the globe. Clario (US) and Dr. Vince Clinical Research (DVCR) (US) partnered in August 2023 to deliver innovative cardiac assessments in clinical trials. Clario (US) can provide precise and economical cardiac safety data early in the clinical development process thanks to the strategic partnership.

Key Players Landscape and Outlook

Several companies such as Laboratory Corporation of America Holdings, Medpace Holdings, Inc., Koninklijke Philips N.V., Clario, Ncardia Services B.V., IQVIA Holdings, Inc., Certara, Inc., ICON PLC., WuXi Biologics Cayman Inc., Eurofins Scientific SE are expanding their businesses by planning and adopting new strategies. They are complying with the new strategic initiatives regarding the launches of newly developed cardiac safety devices to increase their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments and partnerships are a few ways through which they are trying to achieve the same.

FIFPRO and IDOVEN established a strategic partnership in August 2022 with the aim of enhancing player health protections against cardiac arrest and other heart-related hazards. Novocardia introduced a novel heart failure programme in May 2022 that improves the lives of heart failure patients and reduces the need for hospital stays by combining remote patient monitoring with individualized health coaching.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Cardiac Safety Services Market Outlook, 2017-2031F

• 4.1.Market Size & Forecast
  • 4.1.1.By Value
• 4.2.By Type
  • 4.2.1.Integrated Services
  • 4.2.2.Standalone Services
• 4.3.By Application Type
  • 4.3.1.ECG/Holter Measurement Services
  • 4.3.2.Blood Pressure Measurement Services
  • 4.3.3.Cardiovascular Imaging Services
  • 4.3.4.Thorough QT Services
  • 4.3.5.Others
• 4.4.By End-user
  • 4.4.1.Pharmaceutical and Biopharmaceutical Companies
  • 4.4.2.Contract Research Organizations
  • 4.4.3.Academic and Research Institutes
• 4.5.By Region
  • 4.5.1.North America
  • 4.5.2.Europe
  • 4.5.3.Asia-Pacific
  • 4.5.4.South America
  • 4.5.5.Middle East and Africa
• 4.6.By Company Market Share (%), 2023

5.Global Cardiac Safety Services Market Outlook, By Region, 2017-2031F

• 5.1.North America*
  • 5.1.1.Market Size & Forecast
    • 5.1.1.1.By Value
  • 5.1.2.By Type
    • 5.1.2.1.Integrated Services
    • 5.1.2.2.Standalone Services
  • 5.1.3.By Application Type
    • 5.1.3.1.ECG/Holter Measurement Services
    • 5.1.3.2.Blood Pressure Measurement Services
    • 5.1.3.3.Cardiovascular Imaging Services
    • 5.1.3.4.Thorough QT Services
    • 5.1.3.5.Others
  • 5.1.4.By End-user
    • 5.1.4.1.Pharmaceutical and Biopharmaceutical Companies
    • 5.1.4.2.Contract Research Organizations
    • 5.1.4.3.Academic and Research Institutes
  • 5.1.5.United States*
    • 5.1.5.1.Market Size & Forecast
      • 5.1.5.1.1.By Value
    • 5.1.5.2.By Type
      • 5.1.5.2.1.Integrated Services
      • 5.1.5.2.2.Standalone Services
    • 5.1.5.3.By Application Type
      • 5.1.5.3.1.ECG/Holter Measurement Services
      • 5.1.5.3.2.Blood Pressure Measurement Services
      • 5.1.5.3.3.Cardiovascular Imaging Services
      • 5.1.5.3.4.Thorough QT Services
      • 5.1.5.3.5.Others
    • 5.1.5.4.By End-user
      • 5.1.5.4.1.Pharmaceutical and Biopharmaceutical Companies
      • 5.1.5.4.2.Contract Research Organizations
      • 5.1.5.4.3.Academic and Research Institutes
  • 5.1.6.Canada
  • 5.1.7.Mexico

All segments will be provided for all regions and countries covered

• 5.2.Europe
  • 5.2.1.Germany
  • 5.2.2.France
  • 5.2.3.Italy
  • 5.2.4.United Kingdom
  • 5.2.5.Russia
  • 5.2.6.Netherlands
  • 5.2.7.Spain
  • 5.2.8.Turkey
  • 5.2.9.Poland
• 5.3.Asia-Pacific
  • 5.3.1.India
  • 5.3.2.China
  • 5.3.3.Japan
  • 5.3.4.Australia
  • 5.3.5.Vietnam
  • 5.3.6.South Korea
  • 5.3.7.Indonesia
  • 5.3.8.Philippines
• 5.4.South America
  • 5.4.1.Brazil
  • 5.4.2.Argentina
• 5.5.Middle East and Africa
  • 5.5.1.Saudi Arabia
  • 5.5.2.UAE
  • 5.5.3.South Africa

6.Market Mapping, 2023

• 6.1.By Type
• 6.2.By Application
• 6.3.By Technology
• 6.4.By End-user
• 6.5.By Region

7.Macro Environment and Industry Structure

• 7.1.Demand Supply Analysis
• 7.2.Value Chain Analysis
• 7.3.PESTEL Analysis
  • 7.3.1.Political Factors
  • 7.3.2.Economic System
  • 7.3.3.Social Implications
  • 7.3.4.Technological Advancements
  • 7.3.5.Environmental Impacts
  • 7.3.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.4.Porter's Five Forces Analysis
  • 7.4.1.Supplier Power
  • 7.4.2.Buyer Power
  • 7.4.3.Substitution Threat
  • 7.4.4.Threat From New Entrant
  • 7.4.5.Competitive Rivalry

8.Market Dynamics

• 8.1.Growth Drivers
• 8.2.Growth Inhibitors (Challenges and Restraints)

9.Innovations/Emerging Technologies

10.Key Players Landscape

• 10.1.Competition Matrix of Top Five Market Leaders
• 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4.SWOT Analysis (For Five Market Players)
• 10.5.Patent Analysis (If Applicable)

11.Case Studies

12.Key Players Outlook

• 12.1.Laboratory Corporation of America Holdings
  • 12.1.1.Company Details
  • 12.1.2.Key Management Personnel
  • 12.1.3.Products and Services
  • 12.1.4.Financials (As reported)
  • 12.1.5.Key Market Focus and Geographical Presence
  • 12.1.6.Recent Developments
• 12.2.Medpace Holdings, Inc.
• 12.3.Koninklijke Philips N.V.
• 12.4.Clario
• 12.5.Ncardia Services B.V.
• 12.6.IQVIA Holdings, Inc.
• 12.7.Certara, Inc.
• 12.8.ICON PLC.
• 12.9.WuXi Biologics Cayman Inc.
• 12.10.Eurofins Biopharma Product Testing India Pvt Ltd

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

13.Strategic Recommendations

14.About Us & Disclaimer